Veterinary Medicines

DILPHES 4

Authorised
  • Pasteurella multocida, serotype A, strain NCTC 12177, Inactivated
  • Pasteurella multocida, serotype 6B, strain CECT 962, Inactivated
  • Mannheimia haemolytica, serotype A1, strain ATCC 33365, Inactivated
  • Mannheimia haemolytica, serotype A2, strain CECT 924, Inactivated
Download as PDF

Product identification

Medicine name:
DILPHES 4
Active substance:
  • Pasteurella multocida, serotype A, strain NCTC 12177, Inactivated
  • Pasteurella multocida, serotype 6B, strain CECT 962, Inactivated
  • Mannheimia haemolytica, serotype A1, strain ATCC 33365, Inactivated
  • Mannheimia haemolytica, serotype A2, strain CECT 924, Inactivated
Target species:
  • Cattle
  • Sheep
  • Goat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Pasteurella multocida, serotype A, strain NCTC 12177, Inactivated
    4.00
    50% Protective Dose
    /
    2.00
    millilitre(s)
  • Pasteurella multocida, serotype 6B, strain CECT 962, Inactivated
    4.00
    50% Protective Dose
    /
    2.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A1, strain ATCC 33365, Inactivated
    41.08
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A2, strain CECT 924, Inactivated
    41.08
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • CZ Vaccines S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cz Veterinaria S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3177 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 4/06/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 4/06/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 4/06/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."